Recent research focusing on Semaglutide at a dosage of 40mg is shedding new light on its potential applications. Initial findings suggest that this higher dosage may enhance the drug's ability to control blood levels, potentially offering improved outcomes for individuals with insulin resistance. Further research is underway to fully explore the lo